CKD-Associated Cardiovascular Mortality in the United States: Temporal Trends From 1999 to 2020.
Cardiovascular mortality
chronic kidney disease
race differences
Journal
Kidney medicine
ISSN: 2590-0595
Titre abrégé: Kidney Med
Pays: United States
ID NLM: 101756300
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
entrez:
23
2
2023
pubmed:
24
2
2023
medline:
24
2
2023
Statut:
epublish
Résumé
Chronic kidney disease (CKD) is associated with an increased risk of cardiovascular (CV) mortality, but there are limited data on temporal trends disaggregated by sex, race, and urban/rural status in this population. Retrospective observational study. The Centers for Disease Control and Prevention Wide-Ranging, Online Data for Epidemiologic Research database. Patients with CKD and end-stage kidney disease (ESKD) stratified according to key demographic groups. Etiologies of CKD- and ESKD-associated mortality between 1999 and 2000. Presentation of age-adjusted mortality rates (per 100,000 people) characterized by CV categories, ethnicity, sex (male or female), age categories, state, and urban/rural status. Between 1999 and 2020, we identified 1,938,505 death certificates with CKD (and ESKD) as an associated cause of mortality. Of all CKD-associated mortality, the most common etiology was CV, with 31.2% of cases. Between 1999 and 2020, CKD-related age-adjusted mortality increased by 50.2%, which was attributed to an 86.6% increase in non-CV mortality but a 7.1% decrease in CV mortality. Black patients had a higher rate of CV mortality throughout the study period, although Black patients experienced a 38.6% reduction in mortality whereas White patients saw a 2.7% increase. Hispanic patients experienced a greater reduction in CV mortality over the study period (40% reduction) compared to non-Hispanic patients (3.6% reduction). CV mortality was higher in urban areas in 1999 but in rural areas in 2020. Reliance on accurate characterization of causes of mortality in a large dataset. Among patients with CKD-related mortality in the United States between 1999 and 2020, there was an increase in all-cause mortality though a small decrease in CV-related mortality. Overall, temporal decreases in CV mortality were more prominent in Hispanic versus non-Hispanic patients and Black patients versus White patients.
Identifiants
pubmed: 36814454
doi: 10.1016/j.xkme.2022.100597
pii: S2590-0595(22)00230-8
pmc: PMC9939730
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100597Informations de copyright
© 2022 The Authors.
Références
J Am Soc Nephrol. 2015 Oct;26(10):2504-11
pubmed: 25733525
N Engl J Med. 2021 Jan 28;384(4):388-389
pubmed: 33503360
Circ Heart Fail. 2011 Mar;4(2):138-44
pubmed: 21216838
Fam Pract. 2013 Jun;30(3):282-9
pubmed: 23248235
J Am Soc Nephrol. 2002 Mar;13(3):745-753
pubmed: 11856780
Circulation. 2022 Jul 19;146(3):211-228
pubmed: 35861764
JAMA. 2020 May 12;323(18):1852-1854
pubmed: 32396176
JAMA. 2009 Oct 28;302(16):1782-9
pubmed: 19861670
J Am Soc Nephrol. 2016 Nov;27(11):3488-3497
pubmed: 27151925
Am J Nephrol. 2022;53(1):32-40
pubmed: 35016183
Circ Cardiovasc Qual Outcomes. 2022 Jan;15(1):e007917
pubmed: 35041484
Clin J Am Soc Nephrol. 2010 May;5(5):828-35
pubmed: 20200149
Kidney Int Suppl (2011). 2017 Oct;7(2):71-87
pubmed: 30675422
Int J Cardiol. 2021 Apr 15;329:115-122
pubmed: 33321128
Am J Nephrol. 2018;47(3):200-207
pubmed: 29558745
J Am Coll Cardiol. 2021 Jul 27;78(4):330-343
pubmed: 33989713
Am J Kidney Dis. 2011 Jul;58(1):64-72
pubmed: 21458896
NCHS Data Brief. 2021 Sep;(417):1-8
pubmed: 34582331
Am J Kidney Dis. 2019 Jan;73(1):102-111
pubmed: 29661541
BMC Nephrol. 2014 Aug 23;15:136
pubmed: 25150057
Curr Cardiol Rep. 2014;16(10):530
pubmed: 25135343
J Am Soc Nephrol. 2015 Oct;26(10):2512-20
pubmed: 26045089
Clin J Am Soc Nephrol. 2011 Aug;6(8):1858-65
pubmed: 21784835
Clin J Am Soc Nephrol. 2011 Jul;6(7):1722-30
pubmed: 21734088
N Engl J Med. 2023 Jan 12;388(2):117-127
pubmed: 36331190
Ann Intern Med. 2018 Apr 17;168(8):541-549
pubmed: 29554692
Am J Kidney Dis. 2013 Aug;62(2):228-35
pubmed: 23369826
J Am Soc Nephrol. 2005 Dec;16(12):3728-35
pubmed: 16251239
JAMA. 2012 May 9;307(18):1941-51
pubmed: 22570462
Arch Intern Med. 2006 Jul 10;166(13):1396-402
pubmed: 16832005
J Card Fail. 2021 Jun;27(6):622-624
pubmed: 33848650
N Engl J Med. 2021 Dec 9;385(24):2252-2263
pubmed: 34449181
Am J Cardiol. 2008 Dec 15;102(12):1668-73
pubmed: 19064021
Am J Kidney Dis. 2013 Aug;62(2):245-52
pubmed: 23566637
BMJ. 2010 Sep 30;341:c4986
pubmed: 20884698
J Am Soc Nephrol. 2006 Oct;17(10):2910-8
pubmed: 16988065
PLoS One. 2021 Jul 12;16(7):e0254554
pubmed: 34252153
Kidney Int Suppl (2011). 2011 Jun;1(1):21-23
pubmed: 25028623
J Am Soc Nephrol. 2008 Jul;19(7):1403-10
pubmed: 18385428
Circulation. 2022 Mar;145(9):693-712
pubmed: 35226558